FOSIBAIT is a phosphate binder used to treat hyperphosphatemia in patients with end-stage renal disease on dialysis. Lanthanum carbonate binds to phosphate in the intestine, reducing its absorption into the bloodstream. This helps maintain appropriate phosphate levels and prevents complications such as bone disorders and vascular calcification.
Recommended for:
Dialysis patients with elevated phosphate levels
Management of mineral and bone disorders
Chronic kidney disease-related phosphorus imbalance
When standard phosphate binders are ineffective
Hyperphosphatemia in adult patients with chronic kidney disease on dialysis
Take tablets with meals. They may be chewed or broken before swallowing. Dosage is adjusted based on serum phosphate levels and must be determined by a healthcare professional. Regular monitoring of phosphate is essential.
Hypersensitivity to lanthanum carbonate
Gastrointestinal ulceration or obstruction
Phenylketonuria
Pregnancy and breastfeeding (without medical advice)
Under 18 years of age
Nausea, constipation, diarrhoea
Abdominal pain
Bloating
Loss of appetite
Skin rash or itching
